Reduce cardiovascular risk through close follow up of the metabolic syndrome during menopause in women: a possible goal

After a treatment period a significant reduction of BMI. HDL-cholesterol, tryglicerides, diastolic blood pressure and fasting blood glucose, in menopausal women with metabolic syndrome, were performed, as well as a significant reduction of score of relative cardiovascular risk

Costruzione e validazione di uno strumento per la valutazione dell’amabilità

Metformina e pioglitazone in soggetti affetti da diabete mellito tipo 2 con steatosi epatica